Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. FDA Head Asks Congress For Import-Drug Inspection Funds

This article was originally published in PharmAsia News

Executive Summary

The head of the U.S. FDA broke with the administration to tell Congress his agency needs another $275 million if it is to inspect imported drugs and medical devices. Commissioner Andrew von Eschenbach wrote to a key senator to cite the need for offices in other countries and increased inspections. The funding request is beyond the administration's budget request submitted earlier this year. Since then, FDA has been under pressure to ensure the safety of drug imports in the wake of the tainted heparin scare in China. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts